{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:23:09Z","timestamp":1789125789884,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yazeed M. Asiri"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00939-7","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:12:10Z","timestamp":1789117930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis and multitarget evaluation of cyclopropyl-appended thiohydantoin derivatives as dual cholinesterase and COX inhibitors with antioxidant activity: a combined experimental and computational study"],"prefix":"10.1007","volume":"40","author":[{"given":"Amina","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaqat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Sarfraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hasnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibghat Mansoor","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazeed M.","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zainab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"939_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117277","volume":"286","author":"U Azam","year":"2025","unstructured":"Azam U, Naseer MM, Rochais C (2025) Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer\u2019s disease. Eur J Med Chem 286:117277","journal-title":"Eur J Med Chem"},{"key":"939_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","volume":"20","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, Grupper MF, Rautalin I (2025) World stroke organization: global stroke fact sheet 2025. Int J Stroke 20:132\u2013144","journal-title":"Int J Stroke"},{"key":"939_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/ph18081117","volume":"18","author":"M Kruk-S\u0142omka","year":"2025","unstructured":"Kruk-S\u0142omka M, Kuce\u0142 D, Ma\u0142ysz M, Machnikowska A, Orzelska-G\u00f3rka J, Bia\u0142a G (2025) New approaches to the treatment of Alzheimer\u2019s disease. Pharmaceuticals (Basel) 18:1117","journal-title":"Pharmaceuticals (Basel)"},{"key":"939_CR4","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s40120-025-00815-w","volume":"14","author":"MA Cavaco","year":"2025","unstructured":"Cavaco MA, Jang SR, Olsen C, Bodnar C, Ferko N (2025) Global societal burden of Alzheimer\u2019s disease by severity: a targeted literature review. Neurol Ther 14:1797\u20131826","journal-title":"Neurol Ther"},{"key":"939_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Kong G, Yang J, Pang L, Li X (2025) Pathological mechanisms and treatment progression of Alzheimer\u2019s disease. Eur J Med Res 30:625","journal-title":"Eur J Med Res"},{"key":"939_CR6","doi-asserted-by":"crossref","unstructured":"Rahman A, Jaiswal A, Keshari P, Singh DK, (2025) Alzheimer\u2019s: epidemiology, pathophysiology, diagnosis, and treatments, in: Proteostasis: Investigating molecular dynamics in neurodegenerative disorders, Springer, pp. 39-72","DOI":"10.1007\/978-981-96-6202-9_2"},{"key":"939_CR7","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s10787-026-02151-3","volume":"34","author":"RE Mostafa","year":"2026","unstructured":"Mostafa RE, Asaad GF (2026) Bridging the gaps in Alzheimer\u2019s disease: a comprehensive review of current and emerging therapies. Inflammopharmacology 34:2219\u20132241","journal-title":"Inflammopharmacology"},{"key":"939_CR8","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam M-M, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933","journal-title":"Brain"},{"key":"939_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27061816","volume":"27","author":"Z-R Chen","year":"2022","unstructured":"Chen Z-R, Huang J-B, Yang S-L, Hong F-F (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27:1816","journal-title":"Molecules"},{"key":"939_CR10","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1007\/s00210-024-03188-3","volume":"397","author":"SM Firdous","year":"2024","unstructured":"Firdous SM, Khan SA, Maity A (2024) Oxidative stress\u2013mediated neuroinflammation in Alzheimer\u2019s disease. Naunyn-Schmiedebergs Arch Pharmacol 397:8189\u20138209","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"939_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22183","volume":"85","author":"B Kilic","year":"2024","unstructured":"Kilic B, Dogruer DS (2024) Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N\u2019-(quinolin-4-ylmethylene)propanehydrazides against Alzheimer\u2019s disease. Drug Dev Res 85:e22183","journal-title":"Drug Dev Res"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 29:1669\u20131681","journal-title":"Inflammopharmacology"},{"key":"939_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101729","volume":"31","author":"N Moussa","year":"2023","unstructured":"Moussa N, Dayoub N (2023) Exploring the role of COX-2 in Alzheimer\u2019s disease: potential therapeutic implications of COX-2 inhibitors. Saudi Pharm J 31:101729","journal-title":"Saudi Pharm J"},{"key":"939_CR14","doi-asserted-by":"publisher","first-page":"8712","DOI":"10.1021\/acs.jmedchem.6b00472","volume":"59","author":"TT Talele","year":"2016","unstructured":"Talele TT (2016) The \u201ccyclopropyl fragment\u201d is a versatile player that frequently appears in preclinical\/clinical drug molecules. J Med Chem 59:8712\u20138756","journal-title":"J Med Chem"},{"key":"939_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1039\/D0MD00370K","volume":"12","author":"MR Bauer","year":"2021","unstructured":"Bauer MR, Di Fruscia P, Lucas SCC, Michaelides IN, Nelson JE, Storer RI, Whitehurst BC (2021) Put a ring on it: application of small aliphatic rings in medicinal chemistry. RSC Med Chem 12:448\u2013471","journal-title":"RSC Med Chem"},{"key":"939_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202404791","volume":"31","author":"AG Chaidali","year":"2025","unstructured":"Chaidali AG, Terzidis MA, Lykakis IN (2025) Nitrocyclopropanes as valuable building blocks in organic synthesis and biology: exploring the origin of the nitro group. Chem-Eur J 31:e202404791","journal-title":"Chem-Eur J"},{"key":"939_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1017\/S1092852922000906","volume":"28","author":"V Van den Eynde","year":"2023","unstructured":"Van den Eynde V, Abdelmoemin WR, Abraham MM, Amsterdam JD, Anderson IM, Andrade C, Baker GB, Beekman AT, Berk M, Birkenh\u00e4ger TK (2023) The prescriber\u2019s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr 28:427\u2013440","journal-title":"CNS Spectr"},{"key":"939_CR18","doi-asserted-by":"crossref","unstructured":"Kwong J, Grayson ML, (2017) Ciprofloxacin, in: Kucers\u2019 The Use of Antibiotics, CRC Press, pp. 1867-1985.","DOI":"10.1128\/9781498747950"},{"key":"939_CR19","doi-asserted-by":"publisher","first-page":"q183","DOI":"10.1136\/bmj.q183","volume":"384","author":"G Iacobucci","year":"2024","unstructured":"Iacobucci G (2024) Fluoroquinolone antibiotics: Prescribe only as last resort, says UK regulator. BMJ: Br Med J (Online) 384: q183","journal-title":"BMJ: Br Med J (Online)"},{"key":"939_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2026.118761","author":"W Liu","year":"2026","unstructured":"Liu W, Huang Y, Hao W, Rong Z, Liu X, Zhou Y, Song S, Pang X (2026) Cyclopropyl as a versatile tool in the development of kinase-targeted therapeutics. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2026.118761","journal-title":"Eur J Med Chem"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"8946","DOI":"10.1080\/10406638.2022.2157027","volume":"43","author":"A Saeed","year":"2023","unstructured":"Saeed A, Ejaz SA, Saeed M, Channar PA, Aziz M, Fayyaz A, Zargar S, Wani TA, Alanazi H, Alharbi M (2023) Synthesis, biochemical characterization, and in-silico investigations of acyl-3-(Ciprofloxacinyl) thioureas as inhibitors of carbonic anhydrase-II. Polycycl Aromat Compd 43:8946\u20138964","journal-title":"Polycycl Aromat Compd"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1021\/acs.jafc.3c06696","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang Y, Wang S, Cai Q, Song H, Chen J (2024) Discovery and mechanism of a nematicide candidate (W3): a novel amide compound containing a cyclopropyl moiety. J Agric Food Chem 72:5585\u20135594","journal-title":"J Agric Food Chem"},{"key":"939_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2025.110304","volume":"765","author":"H Zaman","year":"2025","unstructured":"Zaman H, Saeed A, Ismail H, Rashid M (2025) Unveiling the cyclopropyl appended acyl thiourea derivatives as antimicrobial, \u03b1-amylase and proteinase K inhibitors: design, synthesis, biological evaluation, molecular docking, DFT and ADMET studies. Arch Biochem Biophys 765:110304","journal-title":"Arch Biochem Biophys"},{"key":"939_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/17568919.2025.2594969","volume":"18","author":"MT Nemr","year":"2026","unstructured":"Nemr MT, Elshaier YA, Ewieda SY, Abdelaziz MA (2026) Pharmaceutical applications of cyclopropyl containing scaffolds: a review on recent updates. Future Med Chem 18:79\u201388","journal-title":"Future Med Chem"},{"key":"939_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1389557520666200729161150","volume":"21","author":"M-R Sun","year":"2021","unstructured":"Sun M-R, Li H-L, Ba M-Y, Cheng W, Zhu H-L, Duan Y-T (2021) Cyclopropyl scaffold: a generalist for marketed drugs. Mini Rev Med Chem 21:150\u2013170","journal-title":"Mini Rev Med Chem"},{"key":"939_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ejmech.2018.12.066","volume":"164","author":"S Cho","year":"2019","unstructured":"Cho S, Kim S-H, Shin D (2019) Recent applications of hydantoin and thiohydantoin in medicinal chemistry. Eur J Med Chem 164:517\u2013545","journal-title":"Eur J Med Chem"},{"key":"939_CR27","first-page":"241","volume":"15","author":"A Errayes","year":"2025","unstructured":"Errayes A, Darwish M, Alzaedi A (2025) Chemical synthesis strategies for thiohydantoin derivatives: a comprehensive review, mediterranean. J Chem 15:241\u2013255","journal-title":"J Chem"},{"key":"939_CR28","doi-asserted-by":"publisher","first-page":"39367","DOI":"10.1039\/C9RA08690K","volume":"9","author":"W Tejchman","year":"2019","unstructured":"Tejchman W, Orwat B, Korona-G\u0142owniak I, Barbasz A, Kownacki I, Latacz G, Handzlik J, \u017bes\u0142awska E, Malm A (2019) Highly efficient microwave synthesis of rhodanine and 2-thiohydantoin derivatives and determination of relationships between their chemical structures and antibacterial activity. RSC Adv 9:39367\u201339380","journal-title":"RSC Adv"},{"key":"939_CR29","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1021\/acs.jnatprod.9b00527","volume":"82","author":"TH Lee","year":"2019","unstructured":"Lee TH, Khan Z, Kim SY, Lee KR (2019) Thiohydantoin and hydantoin derivatives from the roots of Armoracia rusticana and their neurotrophic and anti-neuroinflammatory activities. J Nat Prod 82:3020\u20133024","journal-title":"J Nat Prod"},{"key":"939_CR30","first-page":"971","volume":"76","author":"H Abd Elhady","year":"2019","unstructured":"Abd Elhady H, El Desoky S, Al-Shareef HF, El-mekawy R (2019) Synthesis, reactions, and applications of hydantoin and 2-thiohydantoin derivatives. Acta Pol Pharm Drug Res 76:971\u2013986","journal-title":"Acta Pol Pharm Drug Res"},{"key":"939_CR31","doi-asserted-by":"publisher","DOI":"10.2174\/0113895575329643241206101210","author":"AK Gupta","year":"2025","unstructured":"Gupta AK, Thakur GS, Jain SK (2025) Recent development in hydantoins, thiohydantoins, and selenohydantoins as anticancer agents: structure-activity relationship and design strategies. Mini Rev Med Chem. https:\/\/doi.org\/10.2174\/0113895575329643241206101210","journal-title":"Mini Rev Med Chem"},{"key":"939_CR32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F, Taplin M-E, Sternberg CN, Miller K, De Wit R, Mulders P, Chi KN, Shore ND (2012) Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367:1187\u20131197","journal-title":"N Engl J Med"},{"key":"939_CR33","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","volume":"378","author":"MR Smith","year":"2018","unstructured":"Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H (2018) Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med 378:1408\u20131418","journal-title":"N Engl J Med"},{"key":"939_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107601","volume":"150","author":"IA Seliem","year":"2024","unstructured":"Seliem IA (2024) DMF-DMA catalyzed synthesis, molecular docking, in-vitro, in-silico design, and binding free energy studies of novel thiohydantoin derivatives as antioxidant and antiproliferative agents targeting EGFR tyrosine kinase and aromatase cytochrome P450 enzyme. Bioorg Chem 150:107601","journal-title":"Bioorg Chem"},{"key":"939_CR35","doi-asserted-by":"publisher","first-page":"28100","DOI":"10.1038\/s41598-025-13538-7","volume":"15","author":"A Bukhari","year":"2025","unstructured":"Bukhari A, Nadeem H, Zulfiqar I, Anwar M, Masaud SM, Murtaza B (2025) Synthesis and evaluation of novel thiohydantoin derivatives for antidiabetic activity using in silico in vitro and in vivo methods. Sci Rep 15:28100","journal-title":"Sci Rep"},{"key":"939_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.137565","volume":"1303","author":"AI Khodair","year":"2024","unstructured":"Khodair AI, Metwally AI, Kheder NA, El\u2013Tahawy MMT (2024) New bis-hydantoin\/thiohydantoin derivatives: regioselective synthesis, antibacterial activity, molecular docking, and computational insights. J Mol Struct 1303:137565","journal-title":"J Mol Struct"},{"key":"939_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/acsmedchemlett.7b00230","volume":"8","author":"A Buchynskyy","year":"2017","unstructured":"Buchynskyy A, Gillespie JR, Herbst ZM, Ranade RM, Buckner FS, Gelb MH (2017) 1-Benzyl-3-aryl-2-thiohydantoin derivatives as new anti-Trypanosoma brucei agents: SAR and in vivo efficacy. ACS Med Chem Lett 8:886\u2013891","journal-title":"ACS Med Chem Lett"},{"key":"939_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2026.135279","volume":"196","author":"AA Abdelhamid","year":"2026","unstructured":"Abdelhamid AA, Khalaf MM, Gouda M, Nazreen S, Abd El Latif FM, Alam MM, Elhenawy AA, AbdelRahman MM, Hamada A, Abd El-Lateef HM (2026) In silico-guided development of novel S-alkylated thiohydantoin derivatives and in vitro evaluation of their anticancer toxicity. Tetrahedron 196:135279","journal-title":"Tetrahedron"},{"key":"939_CR39","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1016\/j.bmc.2016.06.056","volume":"24","author":"YS Bae","year":"2016","unstructured":"Bae YS, Choi S, Park JJ, Joo JH, Cui M, Cho H, Lee WJ, Lee SH (2016) Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors. Bioorg Med Chem 24:4144\u20134151","journal-title":"Bioorg Med Chem"},{"issue":"26","key":"939_CR40","doi-asserted-by":"publisher","first-page":"39390","DOI":"10.1021\/acsomega.6c04726","volume":"11","author":"OH Hua","year":"2026","unstructured":"Hua OH, Thai HT, Son NLH, Le Ha V, Tran TH, Nguyen VP, Tran Thai H, Hoang Son NL, Huyen Tran T, Phung Nguyen V, Van Anh TT, Le Thi H, DucCuong N, Van Tat P (2026) Development of novel inhibitors for Alzheimer\u2019s Disease from Erythrina variegata L. extract-derived clusters using molecular docking, QSAR modeling, quantum chemical calculations, and molecular dynamics simulations. ACS Omega 11(26):39390","journal-title":"ACS Omega"},{"issue":"2","key":"939_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ph19020239","volume":"19","author":"S Akocak","year":"2026","unstructured":"Akocak S, Lolak N, Duran HE, Demir \u00c7etinkaya B, Hashem H, Br\u00e4se S, T\u00fcrke\u015f C (2026) Design and synthesis of 4-arylazo pyrazole carboxamides as dual AChE\/BChE inhibitors: kinetic and in silico evaluation. Pharmaceuticals (Basel) 19(2):239","journal-title":"Pharmaceuticals (Basel)"},{"key":"939_CR42","doi-asserted-by":"crossref","unstructured":"Alharbi HM, Al-Hoshani N, Sarfraz H, Bello AS, Chohan TA, Khan AU, Sardar A, Alwethaynani MS, Sagini HA, Alwabsi HA, Al-Joufi FA. (2026). Optimization of 1-(Difluoromethyl)-6-(1H2 Imidazol-5-yl) Imidazo [1, 5-a] Pyrazin-8 (7H)-one frameworks as promising cholinesterase inhibitors for treating alzheimer\u2019s disease. J Computational Biophys Chem. 1\u201320.","DOI":"10.1142\/S2737416526500663"},{"key":"939_CR43","doi-asserted-by":"crossref","unstructured":"Alharbi HM, Al-Hoshani N, Sameeh MY, Sarfraz H, Chudhary M, Asif F, Khan AU, Hussain R, Mansouri OA, Jamal SB. (2026). Integrating computational and experimental approaches to identify novel Pyrazolo [3, 4-d] pyrimidine-containing thiadiazole frameworks for treating alzheimer\u2019s disease. J Computational Biophys Chemi. 1\u201321.","DOI":"10.1142\/S2737416526500845"},{"issue":"7-8","key":"939_CR44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1515\/znc-2025-0225","volume":"81","author":"RN Hassan","year":"2026","unstructured":"Hassan RN, Sarfraz H, Hussain R, Sardar A, Ali Khan A, Binsaleh AY, Al-Hoshani N, Alwethynani MS, Alkhatib SN, Al-Joufi FA, Hadi Mohamed RAE, Elkhadragy MF (2026) Multiparameter optimization of broad-spectrum thymidine phosphorylase inhibition, ADMET properties, molecular docking, and DFT screening of novel pyrazole-based thiadiazole\/thiazole derivatives. Z Naturforsch C J Biosci 81(7\u20138):577\u2013594","journal-title":"Z Naturforsch C J Biosci"},{"key":"939_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2026.145958","author":"FA Al-Joufi","year":"2026","unstructured":"Al-Joufi FA, Sarfraz H, Khan Y, Chohan TA, Alwaili MA, Al-Hoshani N, Sagini HA, Mansouri OA, Hassan F, Hussain R (2026) Rational-guided design and optimization of 6-fluoro-4-(trifluoromethyl) benzofuran-based thiazole derivatives as potent methionine adenosyltransferase 2A inhibitors: in vitro and in silico approaches. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2026.145958","journal-title":"J Mol Struct"},{"issue":"6","key":"939_CR46","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s13738-025-03216-w","volume":"22","author":"Y Khan","year":"2025","unstructured":"Khan Y, Khan S, Hussain R, Mukhtar A, Sarfraz H, Aminullah S (2025) Medicinal approaches toward diabetes mellitus based on chloro-1 H-indazole-derived triazolo-thiadiazole hybrid derivatives: design, synthesis, characterization, in vitro and in silico insights. J Iran Chem Soc 22(6):1209\u20131227","journal-title":"J Iran Chem Soc"},{"key":"939_CR47","doi-asserted-by":"publisher","first-page":"106635","DOI":"10.1016\/j.fitote.2025.106635","volume":"184","author":"MA Mbock","year":"2025","unstructured":"Mbock MA et al (2025) Safety assessment of Detarium microcarpum Guil. & Perr. (Leguminosae) root bark extract in rats: Acute, sub-acute toxicity, ADMET, molecular docking, and molecular dynamics simulations approach. Fitoterapia 184:106635","journal-title":"Fitoterapia"},{"issue":"8","key":"939_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290576","volume":"18","author":"S Ullah","year":"2023","unstructured":"Ullah S et al (2023) A computational approach to fighting type 1 diabetes by targeting 2C coxsackie B virus protein with flavonoids. PLoS ONE 18(8):e0290576","journal-title":"PLoS ONE"},{"issue":"2","key":"939_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s40203-024-00278-1","volume":"12","author":"KA Oluwafemi","year":"2024","unstructured":"Oluwafemi KA et al (2024) Investigating the effect of 1, 2-dibenzoylhydrazine on Staphylococcus aureus using integrated computational approaches. In Silico Pharmacol 12(2):102","journal-title":"In Silico Pharmacol"},{"key":"939_CR50","doi-asserted-by":"crossref","unstructured":"Aziz M et al, (2023) Exploring the therapeutic potential of cannabis constituents in parkinson\u2019s disease: insights from molecular docking studies. bioRxiv: p. 2023.11. 11.566677.","DOI":"10.1101\/2023.11.11.566677"},{"key":"939_CR51","doi-asserted-by":"crossref","unstructured":"Nagarajan S et al (2023) An in-silico approach of assessments of human serotonin transporter inhibitory potential of various flavonoids for anti-depressants: molecular docking, MM-GBSA, molecular dynamics simulation studies.","DOI":"10.21203\/rs.3.rs-3272416\/v1"},{"key":"939_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101486","volume":"47","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee NH et al (2024) Unveiling the antiviral activity of 2\u2032, 3, 5, 7-Tetrahydroxyflavanone as potential inhibitor of chikungunya virus envelope glycoprotein. Inform Med Unlocked 47:101486","journal-title":"Inform Med Unlocked"},{"issue":"6","key":"939_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0341938","volume":"21","author":"K Karunarathne","year":"2026","unstructured":"Karunarathne K et al (2026) In silico pharmacological analysis of Tinospora cordifolia compounds targeting African swine fever virus B175L. PLoS ONE 21(6):e0341938","journal-title":"PLoS ONE"},{"key":"939_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28207015","volume":"28","author":"R Hussain","year":"2023","unstructured":"Hussain R, Rahim F, Ullah H, Khan S, Sarfraz M, Iqbal R, Suleman F, Al-Sadoon MK (2023) Design, synthesis, in vitro biological evaluation and in silico molecular docking study of benzimidazole-based oxazole analogues: a promising acetylcholinesterase and butyrylcholinesterase inhibitors. Molecules 28:7015","journal-title":"Molecules"},{"issue":"6","key":"939_CR55","doi-asserted-by":"publisher","first-page":"e70012","DOI":"10.1002\/jmr.70012","volume":"38","author":"N Ahmad","year":"2025","unstructured":"Ahmad N, Ambreen N, Ayaz M, Zainab AA, Ahmad I, Elhenawy AA, Zghab I, Shah SAA, Ahmad M (2025) Synthesis, in vitro cholinesterase inhibition, molecular docking, density functional theory analysis of benzimidazole based hydrazone schiff bases. J Mol Recognition 38(6):e70012","journal-title":"J Mol Recognition"},{"issue":"14","key":"939_CR56","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1080\/17568919.2026.2684691","volume":"18","author":"A Shakoor","year":"2026","unstructured":"Shakoor A, Elhenawy AA, Alam A, Ahmad I, Rahman MU, Khan A, Zouidi F, Almutairi TM, Al-Harrasi A, Khan M (2026) Benzimidazole derived hydrazone Schiff bases as potent cholinesterase inhibitors: synthesis, in vitro and in silico approaches. Future Med Chem 18(14):1853\u20131869","journal-title":"Future Med Chem"},{"key":"939_CR57","doi-asserted-by":"crossref","unstructured":"Alam A, Bushra Z, Ayaz M, Elhenawy AA, Rehman NU, Rasheed L, Ahmad, I., Ali M, Latif A and Al-Harrasi A, (2026). Bis-Schiff base derivatives of S-flurbiprofen as potent dual cholinesterase inhibitors: synthesis, in vitro biological evaluation and computational insights. Pure Appl Chem.","DOI":"10.1515\/pac-2026-0753"},{"issue":"5","key":"939_CR58","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1021\/acsomega.2c08108","volume":"8","author":"M Khan","year":"2023","unstructured":"Khan M, Gohar H, Alam A, Wadood A, Shareef A, Ali M, Khalid A, Abdalla AN, Ullah F (2023) Para-substituted thiosemicarbazones as cholinesterase inhibitors: synthesis, in vitro biological evaluation, and in silico study. ACS Omega 8(5):5116","journal-title":"ACS Omega"},{"key":"939_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/14756366.2019.1707196","volume":"35","author":"N Lolak","year":"2020","unstructured":"Lolak N, Boga M, Tuneg M, Karakoc G, Akocak S, Supuran CT (2020) Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile. J Enzyme Inhib Med Chem 35:424\u2013431","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"9","key":"939_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091507","volume":"22","author":"SD Oniga","year":"2017","unstructured":"Oniga SD, Pacureanu L, Stoica CI, Palage MD, Cr\u0103ciun A, Rusu LR, Crisan EL, Araniciu C (2017) COX inhibition profile and molecular docking studies of some 2-(trimethoxyphenyl)-thiazoles. Molecules 22(9):1507","journal-title":"Molecules"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00939-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:03:50Z","timestamp":1789124630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00939-7","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"27 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"232"}}